Senior Programme Lead, Cancer & Diagnostics — Hybrid

NHS Jobs; Glenfield; Hybrid; GBP 65,000 - 75,000; Full time

Benefits offered by this job

Hybrid working

Generous annual leave

Job summary

University Hospitals of Leicester NHS Trust seeks a Senior Programme Manager – Cancer & Diagnostics to lead large-scale transformation across the East Midlands, aligning regional delivery with the NHS 10-Year Cancer Plan. The role emphasizes strategic leadership, programme governance, and improved patient outcomes.

The post involves hybrid working, significant stakeholder engagement, and delivery across cancer performance, diagnostics, and service redesign to reduce waiting times and improve

Qualifications

• Master's degree (or equivalent experience) required.
• Extensive experience leading complex transformation programmes within the NHS or similar organisations.
• Strong understanding of cancer services, diagnostics and operational performance improvement.
• Experience developing long-term strategic plans and translating policy into delivery.
• Outstanding leadership, communication, negotiation and influencing skills.

Responsibilities

• Lead a portfolio of complex, multi-organisational programmes across cancer and diagnostics.
• Provide strategic leadership and translate national policy into regional delivery.
• Drive improvements in Cancer Waiting Times and diagnostic capacity and pathways.
• Oversee Community Diagnostic Centres (CDCs) and regional diagnostic transformation.

Skills

Leadership

Programme management

Strategic influence

Budget governance

Data analysis

Education

Master's degree or equivalent

Doctoral-level qualifications desirable

Job description

University Hospitals of Leicester NHS Trust seeks a Senior Programme Manager – Cancer & Diagnostics to lead large-scale transformation across the East Midlands, aligning regional delivery with the NHS 10-Year Cancer Plan. The role emphasizes strategic leadership, programme governance, and improved patient outcomes.

The post involves hybrid working, significant stakeholder engagement, and delivery across cancer performance, diagnostics, and service redesign to reduce waiting times and improve